Skip to main content
Clinical Trials/NCT06790953
NCT06790953CompletedNot Applicable

Clinical Efficacy of Novel Biogenically Fabricated Titania Nanoparticles Enriched Mouth Wash in Treating the Tooth Dentine Hypersensitivity: a Randamized Clinical Trial

Pakistan Institute of Medical Sciences1 site in 1 country130 target enrollmentStarted: June 13, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
130
Locations
1
Primary Endpoint
Post mouth wash utilization Dentine Hypersensitivity

Study Overview

Brief Summary

Randomized Clinical trial to compare the reduction in dentin hypersensitivity after incorporating biogenically fabricated titania nanoparticles enriched Mouth Wash and Conventional Mouth Wash.Participants ranging between 20-50 years were allocated in two groups. Group A will use Conventional Mouth Wash without Nanoparticles. Group B will use titania nanoparticles enriched Mouth Wash. Both will use them for three months and then their VAS scoring will be checked.

Detailed Description

In this study Novel biogenically fabricated titania nanoparticle reinforced Mouth Wash will be evaluated for dentine sensitivity . Participants following Inclusion criteria will be allocated in this study by Consecutive random sampling technique. Participants will be divided into two groups i.e Group-A and Group-B with dentin sensitivity of 30-80. Group A will be given Conventional Mouth Wash for three months and Group-B will be given titania nanoparticles enriched Mouth Wash for three months for the sensitivity. Sensitivity will be assessed using Visual analog scale (VAS) mean score after 1 month and then three months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Masking Description

This is a triple-blinded study in which the participant, care provider and outcome assessor will be masked

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Participants ranging between 20-50 years, good general health but developed dentine sensitivity associated with tooth surface wear and loss during the past 6 months.
  • •There was no history of allergy.
  • •Participants did not use any mouth wash , dentifrice or medication in the last 3 months.
  • •The involved teeth were viable, non-shaky, devoid of any decay, cracks and fillings.
  • •There was an essential positive response to the provoking Air stimuli.
  • •These teeth should display the visible signs of tooth loss and wear such as : attrition, abrasion, erosion and abfraction.

Exclusion Criteria

  • •Participants that might have developed allergy or used medications during the last 2 weeks or more.
  • •The teeth having cracks, decay and fillings were also excluded. Patients who have undergone any periodontal surgery or gross periodontal issues.
  • •Participants who used any desensitisizing toothpastes/mouthwashes and tooth bleaching agents within 2 months of the trial were also excluded positively.

Arms & Interventions

Group-A: Conventional Mouth wash .

Experimental

Group A will receive conventional mouthwash for treatment of dentin hypersensitivity

Intervention: Group- A Conventional Sensed Mouth Wash (Procedure)

Group-B: Novel Titania nanoparticles Mouth wash

Experimental

Group B will receive novel Titania nano particles reinforced mouthwash for treatment of dentin hypersensitivity

Intervention: Group-B Novel Titania nanoparticles enriched Mouth Wash (Procedure)

Outcomes

Primary Outcomes

Post mouth wash utilization Dentine Hypersensitivity

Time Frame: 3 months

Evaluation of dentine hypersensitivity with Conventional Mouth Wash without titania nanoparticles and Novel Nps Mouth Wash with titania nanoparticles on human tooth dentin. Visual analog scale with scoring from 0 to 100 where Score 100 means worst outcomes.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Afsheen Mansoor

Principal Investigator

Pakistan Institute of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials